Stocksigma LogoStocksigma Logo

Kwality Pharmaceuticals Schedules Board Meeting to Approve Q2 Results

Kwality Pharmaceuticals Limited announced that its Board of Directors will meet on 12th Nov'26 to consider and approve the unaudited standalone and

Kwality Pharmaceuticals Schedules Board Meeting to Approve Q2 Results

Kwality Pharmaceuticals Ltd 路 Intimation 路 12 Nov 2026, 5:30 am

Kwality Pharmaceuticals Schedules Board Meeting to Approve Q2 Results Kwality Pharmaceuticals Limited announced that its Board of Directors will meet on 12th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, pursuant to insider trading regulations, the trading window for dealing in company securities remains closed for designated persons, their immediate relatives, and connected persons until 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Kwality Pharmaceuticals Ltd

All Kwality Pharmaceuticals Ltd announcements